CA2306754A1 - Peptides histoganine et utilisation de ces peptides - Google Patents

Peptides histoganine et utilisation de ces peptides Download PDF

Info

Publication number
CA2306754A1
CA2306754A1 CA002306754A CA2306754A CA2306754A1 CA 2306754 A1 CA2306754 A1 CA 2306754A1 CA 002306754 A CA002306754 A CA 002306754A CA 2306754 A CA2306754 A CA 2306754A CA 2306754 A1 CA2306754 A1 CA 2306754A1
Authority
CA
Canada
Prior art keywords
arg
gln
gly
peptide
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306754A
Other languages
English (en)
Inventor
Simon Lemaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Ottawa
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2219437 external-priority patent/CA2219437A1/fr
Priority claimed from CA002224066A external-priority patent/CA2224066A1/fr
Application filed by Individual filed Critical Individual
Priority to CA002306754A priority Critical patent/CA2306754A1/fr
Publication of CA2306754A1 publication Critical patent/CA2306754A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002306754A 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides Abandoned CA2306754A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002306754A CA2306754A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CA2,219,437 1997-10-24
CA 2219437 CA2219437A1 (fr) 1997-10-24 1997-10-24 Peptides utilises comme analgesiques
CA002224066A CA2224066A1 (fr) 1997-10-24 1998-02-24 Peptides utilises comme analgesiques
CA2,224,066 1998-02-24
CA002306754A CA2306754A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides
PCT/CA1998/001002 WO1999021877A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides

Publications (1)

Publication Number Publication Date
CA2306754A1 true CA2306754A1 (fr) 1999-05-06

Family

ID=27170502

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306754A Abandoned CA2306754A1 (fr) 1997-10-24 1998-10-26 Peptides histoganine et utilisation de ces peptides

Country Status (1)

Country Link
CA (1) CA2306754A1 (fr)

Similar Documents

Publication Publication Date Title
EP0674652B1 (fr) Analogue de dolastatine
EP1025119B1 (fr) Peptides histoganine et utilisation de ces peptides
HU181009B (en) Process for preparing angiotensin-ii analogues with antagonictic activity containing in position 1 sarcosyl,hydroxyacetyl or l-alpha-aminoxy-propionyl group and in positiona 8 esteric group
WO1996040752A1 (fr) Nouveaux derives de la dolastatine, leur preparation et leur utilisation
NO321380B1 (no) Heptapeptid analog med oksytocinantagonistaktivitet, fremgangsmate ved fremstilling derav samt anvendelse derav til fremstilling av medikamenter.
BRPI0715407A2 (pt) peptÍdeos e seus derivados funcionalmente equivalentes, composiÇÕes farmacÊuticas e usos dos mesmos
CA2049743A1 (fr) Antagonistes de la bradykinine
ES2624451T3 (es) Ligandos de melanocortina estabilizados
WO2007139921A2 (fr) N-oxydes de peptides de récepteurs de kappa-opioïdes
CH637111A5 (fr) Composes polypeptidiques a activite thymique ou antagoniste et leurs procedes de synthese.
EP0759772B1 (fr) Tri-, tetra-, penta- et polypeptides et leur usage therapeutique en tant qu'agent antidepresseur
CA2405704C (fr) Analogues de bombesine utilises dans le traitement du cancer
EP0755942B1 (fr) Derive type n-amidino de dermorphin
CA2306754A1 (fr) Peptides histoganine et utilisation de ces peptides
US5767083A (en) Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
AU718320B2 (en) Peptide derivatives
AU718192B2 (en) Peptide derivatives
CA2405724C (fr) Analogues de la substance p destines au traitement du cancer
EP0541654A1 (fr) Peptides
EP0517464A1 (fr) Peptides de régulation du système immunitaire et du système nerveux
US6596692B1 (en) Substance P analogs for the treatment of cancer
US6093797A (en) Tri-, Tetra-, Penta-, and polypeptides and their therapeutic use as an antidepressant agent
CA2219437A1 (fr) Peptides utilises comme analgesiques
US20010007016A1 (en) Peptide derivatives
PT94923B (pt) Processo de preparacao de analogos "pseudo" hexapeptidos, heptapeptidos, octapeptidos e nonapeptidos da lhrh e de composicoes farmaceuticas que os contem

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued